A general universal vaccine against the common cold is scientifically possible.
Recent advancements in cross-reactive immunology and experimental pan-viral vaccines demonstrate that developing a broad or universal vaccine targeting common cold viral families is scientifically possible.
The claim posits that a general universal vaccine against the common cold is scientifically possible. While the common cold is caused by diverse families such as rhinoviruses and coronaviruses, recent research on cross-protective coronavirus vaccines and broader viral epitope strategies indicates that targeting conserved regions across viral strains is scientifically achievable and actively under development.
Tanushree Dangi, Shiyi Li, Pablo Penaloza-MacMaster. Development of a cross-protective common cold coronavirus vaccine. 2025. https://doi.org/10.1101/2025.05.12.653567
This study demonstrates the feasibility of developing cross-protective vaccines targeting multiple strains within a common cold viral subgenus (coronaviruses).
See more details
Nor Isamuddin NH, AbuBakar S, Chin KL, Zainal N. Heterologous immunity and antibody-dependent enhancement in respiratory virus infections.. 2025. https://doi.org/10.1007/s11033-025-11189-5
Recent advances in universal vaccine development highlight the potential of harnessing broad-spectrum and cross-reactive immune mechanisms for respiratory viruses.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt